Artivion | CRY - Betriebsergebnis





Betriebsergebnis Veränderung Datum
Abbott USD 1.36B 775M 2026-09
Accuray USD 4.71M 6.86M 2024-12
AngioDynamics USD -2.51M 5.41M 2025-09
Artivion USD 4.79M 6.85M 2025-12
AtriCure USD 4.35M 5.31M 2026-09
Baxter International USD 314M 38M 2026-09
Becton, Dickinson and Co. USD 1.11B 357M 2026-09
Boston Scientific USD 1.01B 232M 2026-09
Edwards Lifesciences USD 542.7M 23.2M 2026-09
Inogen USD -7.79M 728K 2024-09
Integra LifeSciences USD 42.65M 1.36M 2026-09
J&J USD 6.47B 1B 2026-09
Mesa Laboratories USD 5.78M 2.27M 2024-12
Orthofix International USD 6.12M 1.91M 2025-12
Pfizer USD 662M 5M 2026-09
ResMed USD 454.34M 51.33M 2026-06
Stryker USD 1.79B 687M 2026-06
Tandem Diabetes Care USD -2.37M 11.42M 2026-09
Teleflex USD -105.77M 178.84M 2026-09
Terumo JPY 89.48B 58.03B 2026-06
Trinity Biotech USD -1.79M 481K 2026-03